Citation 133175

WUNDER,A: ANKE,T: KLOSTERMEYER,D: STEGLICH,W:. (1996). LACTARANE TYPE SESQUITERPENOIDS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS AND OTHER, NEW METABOLITES FROM SUBMERGED CULTURES OF LENTINELLUS COCHLEATUS (PERS. EX FR.) KARST.. 51(7/8)

Citation Details

Title	LACTARANE TYPE SESQUITERPENOIDS AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS AND OTHER, NEW METABOLITES FROM SUBMERGED CULTURES OF LENTINELLUS COCHLEATUS (PERS. EX FR.) KARST.
Authors	WUNDER,A: ANKE,T: KLOSTERMEYER,D: STEGLICH,W:
Year	1996
Volume	51
Issue	7/8

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Lentinellus cochleatus (AURISCALPIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	LACTARORUFIN A,DEOXY:	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
7	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	ACTIVE
8	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
9	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
10	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	WEAK ACTIVITY
11	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	ACTIVE
12	LEUKOTRIENE B-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	ACTIVE
13	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTARORUFIN A,DEOXY:	INACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
21	ANTIMYCOBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
24	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
25	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
26	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
27	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
28	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
29	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
30	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
31	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LACTARORUFIN A,DEOXY:	EQUIVOCAL
33	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATACD SPECTRUM REPORTED FOR	BLENNIN A	None
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN A	WEAK ACTIVITY
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN A	WEAK ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN A	WEAK ACTIVITY
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN A	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN A	WEAK ACTIVITY
39	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	ACTIVE
40	DNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	WEAK ACTIVITY
41	RNA SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	WEAK ACTIVITY
42	PROTEIN SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	WEAK ACTIVITY
43	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	ACTIVE
44	LEUKOTRIENE B-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	ACTIVE
45	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN A	INACTIVE
46	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATACD SPECTRUM REPORTED FOR	BLENNIN C	None
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN C	EQUIVOCAL
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN C	EQUIVOCAL
49	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN C	EQUIVOCAL
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN C	EQUIVOCAL
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BLENNIN C	EQUIVOCAL
52	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN C	ACTIVE
53	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN C	ACTIVE
54	PROSTAGLANDIN E2 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BLENNIN C	ACTIVE
55	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	None
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	EQUIVOCAL
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	EQUIVOCAL
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	EQUIVOCAL
59	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	EQUIVOCAL
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	EQUIVOCAL
61	LEUKOTRIENE C-4 INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-CIS-2-EN-1-OL,2-CHLORO-3-(4-METHOXY-PHENYL):	ACTIVE
62	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	LENTINELLONE	None
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LENTINELLONE	EQUIVOCAL
64	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LENTINELLONE	EQUIVOCAL
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LENTINELLONE	EQUIVOCAL
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LENTINELLONE	EQUIVOCAL
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LENTINELLONE	EQUIVOCAL

Citation 133175

Citation Details

Summary

Organisms and Their Experiments (1)

Lentinellus cochleatus (AURISCALPIACEAE)

Show SPARQL Queries (1)

Query 1